Issuer Credit Research
Issuer Flash: Sammaan Capital Limited - FY2026 Results
Issuer Flash: Sammaan Capital Limited - FY2026 Results
Report date: 2026-05-21 Event date: 2026-05-20 Event title: FY2026 Results
1. Flash Conclusion
Sammaan Capital Limited's FY2026 results are, from a credit perspective, an event where "the near-term burden from loss recognition is heavy, but the company may have established a new starting point under IHC support." The company reported a full-year net loss after tax of Rs 7,145 crore and a standalone Q4 FY2026 net loss of Rs 8,101 crore. Q4 included impairment on financial instruments of Rs 2,958 crore and exceptional losses of Rs 6,499 crore, while equity declined from Rs 21,822 crore at FYE2025 to Rs 18,991 crore at FYE2026.
At the same time, on March 31, 2026, the company brought in Avenir Investment RSC Limited of the IHC Group as promoter and received the initial capital infusion of Rs 5,652 crore. According to company disclosure, IHC's current shareholding is 28.5%, rising to 43.5% after warrant conversion. CRISIL, CARE, and ICRA have all updated their domestic long-term ratings to the AA+ level, and expectations of IHC support could improve funding access. However, IHC support is not an explicit guarantee.
As in the issuer_summary prepared on the same date, this Flash views the company as a "sponsor-supported turnaround NBFC."
2. What Was Announced
On May 20, 2026, the company released its Q4 FY2026 and full-year FY2026 results materials. The main figures are as follows.
| Metric | Q4 FY2026 | FY2026 | Credit interpretation |
|---|---|---|---|
| Operating revenue | Rs 1,762.85 crore | Rs 8,166.16 crore | Impairment and exceptional losses are the focus, rather than revenue |
| Finance costs | Rs 1,678.56 crore | Rs 5,618.36 crore | Need to verify improvement in funding costs and refinancing terms |
| Impairment on financial instruments | Rs 2,958.08 crore | Rs 3,627.94 crore | The scale of clean-up in the legacy loan book is large |
| Exceptional loss | Rs 6,499.17 crore | Rs 6,499.17 crore | Explained as a clean-up of non-core and legacy loan assets |
| Net profit/loss after tax | Rs -8,101.40 crore | Rs -7,144.56 crore | Credit-negative in that it materially eroded equity |
| Restarting-point AUM | Not applicable | Rs 53,160 crore | Post-clean-up balance as defined by the company. Gross NPA ratio and net NPA ratio are described as zero |
| Equity | Not applicable | Rs 18,991 crore | Down year on year even after the IHC capital infusion |
| Leverage | Not applicable | 2.7x | Increased from 1.9x at FYE2025 |
The company's restarting-point AUM of Rs 53,160 crore comprises housing finance of Rs 30,962 crore, secured business loans / loans against property and related assets of Rs 10,592 crore, commercial real estate and project-related exposure of Rs 10,346 crore, and other assets of Rs 1,260 crore. The company describes the gross NPA ratio and net NPA ratio for this AUM as zero, but this is a post-clean-up balance presentation and does not mean there will be no future losses.
3. Credit Read-Through
Credit positives are IHC's capital participation and promoter status, the AA+ updates by the three domestic rating agencies, and the large cash and investment balance. The initial capital infusion, unexercised warrants, and involvement in the board, risk management, and finance functions reinforce market confidence and funding capacity. At FYE2026, cash and cash equivalents of Rs 9,027 crore, other bank balances of Rs 1,933 crore, and investments of Rs 17,518 crore also support short-term liquidity.
The credit negatives are also clear. The FY2026 loss actually eroded equity, and the post-clean-up AUM has only a short operating track record. Commercial real estate and project-related balances account for around 20% of the book and overlap with areas where problems were more likely to emerge in the legacy loan book. In addition, CRAR, Tier 1, detailed ALM, unused bank lines, and the collateral, guarantee, and change-of-control clauses of individual bonds remain unconfirmed.
Therefore, these results should not be read as "fully positive because the bad news has been cleared out." In the near term, the loss and decline in capital are credit-negative. At the same time, the company may have advanced the clean-up of the legacy loan book under IHC support and created a base for growth from FY2027 onward. The assessment from here will depend on whether additional losses stop, whether the company returns to profitability, and whether funding terms actually improve.
4. What To Watch Next
The first item to review is the FY2026 annual report. The key areas to confirm are exceptional losses, changes in expected credit losses, stage-wise loans, write-offs, collateral, capital ratios, ALM, and the difference between standalone and consolidated accounts. In Q1 FY2027, the points to verify are normalisation of credit costs, recovery to profitability, delinquencies in the post-clean-up AUM, and a decline in finance costs.
On funding, the important issue is how the debt-raising limit of up to Rs 10,000 crore approved on May 20, 2026 is executed in terms of tenor, interest rate, collateral, and currency. If the company can raise diversified funding at longer tenors, this would demonstrate the effectiveness of IHC support. If funding is skewed toward short-tenor, high-cost, collateral-heavy borrowing, the effect of the AA+ ratings would be limited.
For IHC support, the items to monitor are warrant conversion, shareholding ratio, board composition, additional capital, and whether any guarantee is provided. At this point, support expectations are strong, but no legal guarantee has been confirmed.
5. Unconfirmed Items
- Full FY2026 annual report and auditor's notes.
- Details of exceptional losses, impairment, expected credit losses, stage-wise loans, collateral values, recoveries, and write-offs.
- CRAR, Tier 1, detailed ALM, maturity walls, unused bank lines, CP ratio, and foreign-currency hedging.
- Full rating rationales from CARE Ratings and ICRA, list of rated debt, and upward / downward sensitivities.
- Collateral, guarantees, ranking, and change-of-control clauses for individual NCDs, retail bonds, subordinated bonds, and foreign-currency bonds.
- Live spreads, trading yields, and relative value versus similarly rated NBFC bonds.
6. Sources
- Sammaan Capital Limited, Earnings Update for the quarter and financial year ended March 31, 2026, May 20, 2026: https://www.sammaancapital.com/downloads/SCL_Earnings_Update_20May2026%20%283%29
- Sammaan Capital Limited, Corporate Announcement page, May 2026 entries including CARE rating update: https://www.sammaancapital.com/investors/corporate-announcement
- Sammaan Capital Limited, Sammaan Capital becomes an IHC Group company press release, March 31, 2026: https://www.sammaancapital.com/media/uploads/news/ihcsclpressreleasemarch312026_51206.pdf
- CRISIL Ratings, Sammaan Capital Limited rating rationale, April 09, 2026: https://www.crisil.com/mnt/winshare/Ratings/RatingList/RatingDocs/SammaanCapitalLimited_April%2009_%202026_RR_393429.html
- ICRA public rating page, Sammaan Capital Limited upgrade announcement, May 20, 2026: https://www.icra.in/Rationale/ShowRationaleReport?Id=68476
- Internal structured data extracted from the official sources:
issuer_summary/issuers/sammaan_capital/data/sammaan_capital_key_metrics_20260521.json